Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma.

beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma. J Clin Invest. 1998 Jun 15; 101(12):2720-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.